Skip to content

The significance of monocyte subsets changes induced by gut microbial metabolites in AS and the intervention mechanism research of Huatan Quyu Jiedu Tongmai Formula

The significance of monocyte subsets changes induced by gut microbial metabolites in AS and the intervention mechanism research of Huatan Quyu Jiedu Tongmai Formula

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR1900002730
Enrollment
Unknown
Registered
2019-10-31
Start date
2019-12-02
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atherosclerosis and blood-lipid metabolic disorder

Interventions

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 25-65 years old, male or female; 2. TCM Syndrome differentiation is phlegm stasis; 3. Meeting the diagnostic criteria of atherosclerosis and blood-lipid metabolic disorder; 4. Patients with carotid intima-media thickness (IMT)>=1.0mm or visible plaque and carotid artery stenosis 20 cigarettes per day), obesity (BMI >28), hyperlipidemia and family history; 6. The basic principle of freely given informed consent for all subjects.

Exclusion criteria

Exclusion criteria: 1. Patients with chest pain, dizziness and headache due to cardio-cerebrovascular diseases, such as unstable angina, myocardial infarction, etc. or caused by severe neurosis, menopausal syndrome, other chest diseases and craniocerebral lesions, such as vasculogenic stroke, etc.; 2. Severe liver and kidney function damage, with alanine aminotransferase> 3 times of the upper limit of normal, or serum creatinine was high than the upper limit; 3. Combined with major systemic diseases such as the nervous system, and immune system, or poorly controlled chronic diseases such as hypertension and diabetes; 4. Those who have complicated accompanying syndromes, including deficiency of 'qi' and 'yi', 'zhong-qi sinking' or 'hyperactivity of liver yang'; 5. Allergy constitution; 6. Women of child-bearing age who are in pregnancy or lactation; 7. Patients who participated in other drug clinical trials in the past 1 months; 8. Mental disorders who failure to correctly express wishes or communicate; 9. Drug abusers or addicts.

Design outcomes

Primary

MeasureTime frame
Maximum IMT of anterior and posterior walls of carotid artery;The syndrome scorings of the phlegm stasis;

Secondary

MeasureTime frame
Maximum plaque area of short and long axis of carotid artery;vascular endothelial function;The four methods of diagnosis;Blood biochemistry;Carotid stenosis rate or vessel diameter;

Countries

China

Contacts

Public ContactXiaochang Ma
maxiaochang@x263.net+86 13801039242

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026